Immunotoxin Therapy in Treating Patients With Advanced Cancer - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Immunotoxin Therapy in Treating Patients With Advanced Cancer

This study has been completed.

Study NCT00006981 Information provided by National Cancer Institute (NCI)

First Received: December 6, 2000 Last Updated: February 6, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Cervical Cancer
Fallopian Tube Cancer
Head and Neck Cancer
Lung Cancer
Malignant Mesothelioma
Ovarian Cancer
Pancreatic Cancer
Peritoneal Cavity Cancer

Additional conditions recognized in this trial

Fallopian Tube Neoplasms
Head and Neck Neoplasms
Lung Neoplasms
Mesothelioma
Ovarian Neoplasms
Pancreatic Neoplasms
Peritoneal Neoplasms

Interventions listed in this trial

SS1(dsFv)-PE38 immunotoxin

Additional drug interventions recognized in this trial

Antibodies, Monoclonal
Immunotoxins

More general drug interventions related to this trial

Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs

Sponsors listed in this trial

National Cancer Institute (NCI)

Back to top of Main Content